Genetic recombination is the creation of new gene combinations in a cell or gamete, which differ from those of progenitor cells or parental gametes. In eukaryotes, recombination may occur at mitosis or meiosis. Mitotic recombination plays an indispensable role in DNA repair, which presumably directed its early evolution; the multiplicity of recombination genes and pathways may be best understood in this context, although they have acquired important additional functions in generating diversity, both somatically (increasing the immune repertoire) and in germ line (facilitating evolution). Chromosomal homologous recombination and HsRad51 recombinase expression are increased in both immortal and preimmortal transformed cells, and may favor the occurrence of multiple oncogenic mutations. Tumorigenesis in vivo is frequently associated with karyotypic instability, locus-specific gene rearrangements, and loss of heterozygosity at tumor suppressor loci --all of which can be recombinationally mediated. Genetic defects which increase the rate of somatic mutation (several of which feature elevated recombination) are associated with early incidence and high risk for a variety of cancers. Moreover, carcinogenic agents appear to quite consistently stimulate homologous recombination. If cells with high recombination arise, either spontaneously or in response to "recombinogens," and predispose to the development of cancer, what selective advantage could favor these cells prior tothe occurrence of growth-promoting mutations? We propose that the augmentation of telomere-telomere recombination may provide just such an advantage, to hyper-recombinant cells within a population of telomerase-negative cells nearing their replicative (Hayflick) limit, by extending telomeres in some progeny cells and thus allowing their continued proliferation.
VARIETIES OF RECOMBINATION
Genetic recombination, most broadly defined, refers to the creation of new gene combinations in a diploid cell or gamete, distinct from those of its progenitors. It thus includes reassortment of chromosomes in eukaryotic gametogenesis, termed interchromosoma/recombination, but more commonly refers to intrachromosoma/ events involving DNA strand exchange (breakage and reunion of strands), whether occurring in meiosis or mitosis.
There are four main types of recombination: homologous recombination, site-specific recombination, transposition, and illegitimate recombination. Homologous recombination requires extensive sequence identity between the DNA duplexes to be recombined (Szostak et a/. 1983; West 1994) , and occurs at rates dependent on both the length of "homologous" sequences and the degree to which they are identical (Ayares eta/. 1986; Liskay et al. 1987 ; Nassif and Engels 1993). Sitespecific recombination occurs between DNA duplexes containing characteristic signal sequences that have little or no homology. Site-specific recombination events include rearrangements that generate immunoglobulin and T-cell receptor diversity (Oettinger etaL 1990) , and insertion or excision of transposons and viral DNA. Aberrations of these processes would also qualify, such as chromosomal inversions and translocations in human cancers, primarily leukemias, in which immunoglobulin signal sequences may recombine with signalrelated sequences in or near oncogenes (Battey et aL 1983) . Transposition, usually regarded as a subclass of site-specific recombination, is the process by which blocks of DNA sequence move from one place-to another in a genome. Transposable elements can cause insertional mutation of interrupted genes, and altered expression of nearby genes, and thus may contribute significantly to genomic evolution (Wichman et aL 1992) and somatic mutation (Nikitin and Shmookler . Illegitimate or nonhomologous recombination does not require either a signal sequence or regions of extensive sequence identity. Although its frequency per kilobase of target DNA is much lower than that for homologous recombination, the total over the whole genome can be substantial (Mansour etaL, 1988 (Mansour etaL, , 1993 . Thus, stable integration of transfected DNA occurs predominantly through illegitimate recombination (Waldman and Waldman 1990 ; Sweezy and Fishel 1994) , even when homologous recombination is greatly enhanced by gene targeting with sequences identical to genomic DNA (Folger et aL 1985; Mansour et aL, 1988; Sedivy and Sharp 1989) .
In eukaryotic organisms, recombination occurs both in mitosis and meiosis. Meiotic recombination --in germ-line cells only --augments the reassortment of gene alleles accomplished by segregation of chromosomes at the first meiotic division (Baker et aL 1976). Moreover, meiotic recombination between homologous DNA sequences of multigene families plays a significant role in generating genetic diversity and facilitating the evolution of genes (Amstutz etaL 1985) . Mitotic recombination plays a crucial role in repairing DNA damaged by a variety of agents (Friedberg et al. 1991) , both in somatic tissues and in gametic lineages. Because mitoses greatly exceed meioses in lineages leading to gamete formation, mitotic recombination also contributes greatly to germ-line reassortment and rearrangement of genes (Smith 1974 (Smith , 1976 . Additionally, mitotic homologous recombination is involved in immunoglobulin class switching (Davis et aL 1980; Early et aL 1980; Sakano et aL 1980) , and may underlie the loss of heterozygosity which, in regions containing antioncogenes, contributes to carcinogenesis (Solomon et aL 1991) .
MODELS OF HOMOLOGOUS RECOMBINATION AND GENE CONVERSION
Most of our current understanding of the recombination process, expressed through evolving models of the intermediates involved, derives from tetrad and octad analysis of fungal haploid spores segregating for visible spore phenotypes, wherein all four products of meiotic segregation (the tetrad) can be observed. Actually, in some fungi eight spores are generated per meiosis (an octad), since each of the four haploid products of meiosis is replicated in a final mitosis to yield two spores, normally identical, derived from the two strands of each chromatid's DNA duplex. The haploid state of fungal spores allows segregation and recombination to be easily visualized for markers affecting spore appearance, with the frequency and order of alleles (distinguishable variants of a marker) or diallelic combinations providing important clues as to the underlying processes. Aberrant segregations are most readily analyzed in Neurospora crassa, a bread mold, because the eight spores remain in an ordered linear array within the ascus, or spore pod. Other fungi may produce ordered tetrads (Ustilago), unordered tetrads (the mushroom C. tagopus and the yeast S. cerevisiae), or unordered octads (Neurospora) (Raju 1980) . In >99% of meioses, distinguishable parental forms of single markers, or alleles, segregate in 2:2 ratios (4:4 in octads), as predicted by Mendel and as expected from simple partition of the four parental chromatids. The exceptions (mostly 3:1 or 6:2 ratios) indicate an asymmetric or nonreciprocal process, called "gene conversion" to reflect the apparent transformation of one parental allele to the other. Still more rarely, in octads the paired ascospores representing mitotic products of a single chromatid are not identical, indicating that two strands within a DNA duplex were not quite complementary but comprised a heteroduplex.
A molecular basis for reciprocal and nonreciprocal events in homologous recombination was first proposed by Robin Holliday (1964) based on evidence from Ustilago and Neurospora, fungi which produce ordered meiotic products. According to the Holliday model, recombination is initiated by introduction of a nick in one strand of each of two homologous chromosomes. Strand exchange proceeds from these nicks to produce a crossedstrand "Holliday junction". Branch migration of a crossover leads to the formation of symmetrical heteroduplex regions which contain one strand from each parental chromosome. Holliday structures can be resolved by cutting the uncrossed strands, to generate recombinant chromatids, in which those alleles which differ between homologs are seen to derive from different parents on either side of the crossover. This exchange of flanking markers, the outcome of half of all crossover events, is the defining criterion of genetic recombination. Alternatively, if the resolution is achieved by cutting the originally crossed strands, it will result in nonrecombinant chromosomes, although each would still contain a heteroduplex region corresponding to the span of branch migration. Asymmetric mismatch repair of heteroduplex segments, whether in recombinant or nonrecombinant products, leads to tracts of gene conversion.
A modification of the Holliday model was presented by Meselson and Radding (1975) , in which strand exchange is initiated by a nick in only one of the homologous chromosomes. In 1983, Szostak etaL presented a double-strand break model of recombination in yeast, that accounted for marked biases in the direction of gene conversion (i. e., one of the parental alleles prevailed) in some experimental designs. The model proposes that recombination is initiated by a double-strand break in one of the chromosomes, followed by exonuclease action to produce a gap at the break point. One 3' end invades the homologous duplex, resulting in the formation of a D loop. The repair synthesis of gap DNA is followed by branch migration to form a double-crossover version of the Holliday structure, which can then be resolved to generate recombinant or nonrecombinant chromatids. In this model, as in the experimental data it was devised to explain, a broken chromosome is always the recipient of genetic information, whereas in the Holliday and Meselson-Radding models, the nicked duplex was the donor.
It should be noted that the definition of gene conversion has expanded in popular usage, beyond its original meaning in the context of meiotic segregation distortion. Other nonreciprocal exchanges, even between plasmids or between a chromosomal locus and an identical or related episomal sequence, have been termed gene conversion, as have situations in which the information donor and recipient(s) lie on the same chromatid and the flow of information appears to be unidirectional Subramani 1986, 1987 
RELATIONSHIP OF HOMOLOGOUS RECOMBINATION TO DNA REPAIR
Intrachromosomal homologous recombination, the generation of new assortments of genetic material by DNA strand exchange (usually detected only if between nonsister chromatids), is a fundamental genetic process which occurs ubiquitously in all living organisms. Mechanisms to facilitate homologous recombination must have arisen very early in evolution, very likely as mediators of DNA repair. As described above, the simplest models of homologous recombination involve an initial nicking of DNA duplexes, invasion of partially identical (often termed homologous) sequences in another duplex, displacement of the crossover point by branch migration, and resolution of the crossover intermediate by a second strand exchange (Holliday 1964; Meselson and Radding 1975) . Initiation is now thought to occur primarily with a doublestrand break in the "recipient" DNA duplex, followed by exonucleolytic recission of the broken ends and gap repair directed by a homologous donor duplex (Szostak et aL 1983) . Double-strand break models explain otherwise puzzling features of homologous recombination, account for nonreciprocal information flow --including gene conversion --and place the recombination mechanism firmly in the realm of DNA repair.
Damage to DNA being inevitable, its repair must be regarded among the most fundamental requirements for life. All organisms are exposed to DNA-damaging agents, including exogenous chemicals and radiation, and endogenously-generated oxygen radicals. The resulting lesions (Solomon et aL 1991) include missing bases (e.g., nearly 10,000 spontaneous depurinations per mammalian cell per day), modified bases (due to alkylation and radiation ionization), and incorrect bases (due chiefly to deamination). DNA strands may be affected by insertions or deletions, largely spontaneous in origin, and by double-and single-strand breaks --either caused directly by ionizing radiation, or indirectly via DNA repair, elicited by cross-linking agents, UVinduced cyclobutyl dimers, oxidation, and large adducts. In human cells, oxidative damage has been estimated to be found at nearly 10 .2 of nucleotides in nuclear DNA, and greater than 10 .4 of bases in mitochondrial DNA (Richter et al. 1988; Loft and Poulsen 1996) . DNA lesions are highly mutagenic if unrepaired prior to DNA replication, because they may be bypassed through error-prone (SOS) replication (Kornberg and Baker 1992 ). Higher fidelity is achieved by an alternative pathway for post-replication repair, recombinational repair, wherein gap filling is achieved by recombination with homologous DNA sequences from the other branch of the replication fork. Either mode of post-replication repair is literally a "stopgap" measure, however, which fails to remove the mutagenic lesion but buys time --another cell cycle --for repair. Double-strand breaks not repaired prior to S phase can have dire consequences because such chromatid breaks may recombine to generate chromosomal rearrangements with the potential for oncogenesis or cell lethality. For example, chromosomal fragments losing or gaining a centromere (acentric or dicentric chromosomes) tend to segregate abnormally. Genetic recombination reduces mutations arising from error-prone repair, and is essential for the repair of double-strand breaks (Resnick et aL, 1989; Sweezy and Fishel 1994) ; its occurrence in mitotic cells may thus be predominantly or entirely repair-related (Roca and Cox 1990) . Surprisingly, the repair of DNA damage appears to utilize both homologous and nonhomologous recombination pathways (Sweezy and Fishel 1994) , which are described in greater detail below. Moreover, the Rad52 protein, although intimately involved in homologous recombination through interaction with Rad51, is not required for intrachromosomal "gene conversion" or for repair of several types of DNA damage (Yamaguchi-lwai et aL 1998)
GENES MEDIATING HOMOLOGOUS RECOMBINATION
Homologous recombination has been intensively studied in E. coil, for which the recombination machinery is at present the best characterized (Sengstag 1994) . In this bacterium, the implicated genes encode nucleases (recB, recC, recD, recE, recJ, and ruvC), helicases (recB, recC, recD, and recQ), topoisomerases (gyrA, gyrB, and topA), DNA ligase (lig), DNA-binding proteins (ssb, recF, and recG), proteins mediating strand migration (ruvA and ruvB), and recA recombinase. The RecA protein plays a central role in mediating the cellular SOS response to DNA damage, as well as homologous recombination, in E. coll. This dual role makes sense in the context of DNA repair, since these are precisely the two options available for gap-filling behind the replication fork. The multifunctional RecA protein possesses DNA-dependent ATPase activity, requiring both singlestranded DNA (ssDNA) and ATP, and a protease activity which cleaves LexA and several other DNA-binding repressor proteins. Cleavage of LexA protein triggers the SOS response by relaxing transcriptional repression of DNA-repair genes. RecA is also capable of renaturing ssDNA and pairing homologous DNA sequences, and can mediate the formation of stable triple helices (Hsieh et al. 1990 ). The pairing of homologous DNA sequences, which is an important function of RecA, seems to require only a small peptide containing amino acids 193-212 of the protein (Voloshin et al. 1996 ).
Recombination at double-strand breaks, in E. coil, is initiated by the RecB, C, and D components of a multienzyme helicase/nuclease complex (Taylor etaL 1985) . RecBCD binds one of the free ends created by a doublestrand break and unwinds the duplex to form paired loops of single-stranded DNA. On encountering a "chi" (X) cleavage sequence, the RecBCD nuclease cuts one strand, generating a free 3' end to engage in RecAmediated recombination. The yeast RAD51 and DMCl genes are similar in sequence to the E. coil recA gene (West 1994 ), but no counterpart to recBCD has yet been identified in eukaryotic nuclei. A functional equivalent may exist, however, since eukaryotes have hotspots for homologous recombination analogous to (but distinct from) • sites (Smith 1994 
GENES INVOLVED IN NONHOMOLOGOUS RECOMBINATION
The mechanisms of nonhomologous recombination are relatively poorly understood. However, a number of proteins such as topoisomerase I (Ikeda 1994 1994) , have been implicated to play very specific roles in illegitimate (nonhomologous) recombination. NHR ligase has the ability to join DNA duplexes, irrespective of the sequence and structure of their ends (Derbyshire et aL 1994). Surprisingly, this enzyme was characterized as a component of a multi-enzyme complex which possesses homologous pairing and strandexchange activity. The complex contains homologous pairing protein (HPP-1, which mediates strand exchange proceeding in a 5' to 3' direction), a 3'-exonuclease, and the human single-strand binding (hSSB) protein, in addition to NHR ligase (Sweezy and Fishe11994).
These observations led to a model in which nonhomologous recombination is primarily an end-joining ligation reaction between two DNA duplexes; their single-stranded ends, generated by 3'-exonuclease, anneal by base-pairing over short complementary regions and are then ligated (Sweezy and Fishel 1994) . Thus, nonhomologous recombination would be mediated through regions of partial sequence identityT This is not altogether surprising, given the much greater efficiency of ligation in vitrofor cohesive-end joining than for blunt ends; note, however, that the requirement here for congruent sequences is greatly reduced relative to homologous recombination, which proceeds through a triple-stranded intermediate (Hsieh et aL 1990) and depends directly on the length and degree of identity of homologous sequences (Ayares etal. 1986; Liskay etaL 1987; Nassif and Engels 1993). The two processes may share common enzymatic steps, but clearly also have distinctive features. Forexample, inhibitors of poly(ADPribosylation) block random integration of transfected DNA into the host genome (an example of nonhomologous recombination), but not inter-or intra-molecular homologous recombination between plasmid sequences (Waldman and Waldman 1990 ). Free ends of transfected or broken genomic DNA may induce poly(ADP-ribose) potymerase, which in turn induces double-strand break repair by recruiting and activating DNA ligase II (Creissen and Shall 1982). This mechanism would account for the role of poly(ADPribose)polymerase in the stable integration of transfected DNA into the host genome (Waldman and Waldman 1990 ). However, poly(ADP-ribose) polymerase can also ADP-ribosylate histone H1, which may lead to removal of this histone from nucleosomes to create a relaxed chromatin site, a putative substrate for the integration of transfected DNA (Althaus and Richter 1987) .
Plasmids in eukaryotic cells recombine primarily by a nonhomologous route, probably through annealing of cohesive single-strand regions at damaged DNA ends ( Activated p53 also mediates cell-cycle arrest through trans regulation of target gene expression. One target, p21, inhibits cyclin-dependent kinases (Xiong et aL 1993), thus preventing phosphorylation of Rb and subsequent release of E2F, which is required for transcriptional activation of S-phase-associated genes. Transcriptional activation of other downstream genes such as GADD45 , and WAF1/CIP1 (EIDeiry et aL 1994) has also been implicated in p53-mediated cell cycle arrest. However, the observation that certain DNA-base-damaging agents, such as methyl methane sulfonate (MMS), can induce GADD45 in the absence of functional p53 (Fornace et aL 1989), implies that p53-independent pathways also exist for cell-cycle arrest after DNA damage ). The extent of p53 induction can vary greatly between different DNA damaging agents (Lu and Lane 1993) , and/or cell types (Khanna and Lavin 1993) , which also supports the hypothesis of multiple signal transduction pathways for cell-cycle arrest.
IMPORTANCE OF "RECOMBINOGENS" IN CARCINOGENESIS
Most carcinogens are mutagenic when assayed in Salmonella HIS-reversion assays, but 30-50% are net (Ashby and Tennant 1988; Mason etaL 1990). Of those carcinogens for which point-mutagenicity is not commensurate with oncogenicity, some are active in other HIS-strains requiring small frame-shift insertions or deletions for reversion. However, these assay systems also appear to be inefficient at detecting a subset of carcinogens ( (Zhang and Jenssen 1994) . Using the HPRT-reversion assay in untransformed human fibroblasts, we find substantial recombinogenic activity for 6/6 carcinogens tested, which increase reversion rates by 2.4-to 12-fold even without addition of a metabolic-activation extract, whereas five noncarcinogenic chemicals altered recombination by no more than 1.7-fold (Li etaL 1997). The very high concordance observed between recombinogenicity and carcinogenicity (a perfect 1.0 in this small sample), if confirmed for a larger panel of chemicals and other agents demonstrated to be carcinogens or noncarcinogens, implies that oncogenesis may depend far more on effects stimulating DNA rearrangement than on point mutations. How is this possible, in view of the very wellestablished although weaker association between carcinogens and point mutagens revealed by Ames tests? Indirect effects could resolve this paradox --e.g., high levels of point mutation, by depleting the cell's capacity for coping with base-pairing mismatches, may impede completion of recombinational repair which involves correction of heteroduplex regions.
However, this would be difficult to reconcile with the relative paucity of chromosomal instability in cancer cells deficient in mismatch repair (Lengauer etaL 1997 (Lengauer etaL , 1998 . Alternatively, point mutations might themselves stimulate recombination via mismatch repair. In this case, Ames-positive point mutagens should also be recombinogenic, but only in cells with intact mismatch repair pathways. We are currently testing this hypothesis.
ELEVATED RECOMBINATION AN EXPRESS ROUTE TO IMMORTAL TRANSFORMATION AND CANCER?

Cell immortality
Normal diploid cells decline progressively in cell cycling rate with increasing passage level, effectively limiting their in vitro life spans, whereas established cell lines are able to divide indefinitely and are thus termed "immortal". Transformation by a DNA tumor virus, such as SV40, papillomavirus, Epstein-Barr virus, or adenovirus (specific for the cell type affected), facilitates but is not generally sufficient for cell immortalization (Khoobyarian and Marczynska 1993 Certain types of cancer, usually leukemias, are associated with specific chromosomal translocations affecting the expression or activity of oncogenes and/or antioncogenes (Leder et al. 1983 ; Lakshmi and Sherbet 1990; Duesberg et aL 1991). Analysis of translocation breakpoints is often consistent with aberrant site-specific recombination, which is fully activated during lymphocyte differentiation, but inferences regarding the frequencies of these rare events are compromised by the highly selective nature of such observations (see below).
Site-specific recombination may occasionally utilize incorrect target sequences, causing activation of oncogenes (Bishop, 1987) or deletion of functional alleles of tumor suppressor genes (Weinberg, 1995) .
These must be exceptional outcomes, even among the products of errant (not-so-site-specific) recombination, but are brought to our attention by the enhanced cell proliferation they elicit. Induction of recombination pathways has not been demonstrated in higher eukaryotes, but is suggested by some data (Xia et aL 1997) . Such induction could serve to protect chromosomal structure, or may result in an increased number of chromatid breaks due to initial endonuclease activity. Double-strand breaks in DNA are potentially lethal, because if they escape the repair system and persist from G 2 into mitosis, they are very likely to recombine in G 1 and thus produce gene rearrangements. Free ends of DNA can also stimulate illegitimate recombination by an end-joining reaction which is thought to initiate breakage-fusion-bridge cycles and may generate dicentric and other translocated chromosomes (Duesberg et aL 1991; Sweezy and Fishe11994).
Cancer is a multistep process (Farber 1984; Weinberg 1988, 1995) wherein a normal cell acquires, by mutation, a variety of characteristics in progressing to hyperplasia, benign transformation, and malignancy. Most human tumors carry at least four independent mutations (Neiman and Hartwell 1991) , and colorectal carcinoma is thought to require seven or more genetic events (reviewed in Tsancheva 1997). In the latter group of cancers, mutations in c-k-ras, c-myc, APC, MCC, DCC, and p53genes are found very frequently. The most common subclass, hereditary nonpolyposis colorectal cancer, is associated with mutations in multiple DNA mismatch-correction and repair genes, including hMSH2, hMLH1, hPMS1, hPMS2, and hMSH6/GTBP (Lynch and Lynch 1998 1997) . Multiple mutations also enable tumor progression to increasingly invasive and metastatic phenotypes. To become meta-static, a neoplasia must acquire abilities which are largely or totally lacking in most normal cells, to breach the extracellular matrix, probably by induction of proteases; to bind and traverse the endothelial surface of blood vessels, by over-expressing receptors for endothelial membrane; to survive in blood circulation; and to escape the blood vessel and establish anchorage and proliferation at new foci.
Such successions of phenotypic changes could occur through a series of mutations and clonal expansions, but are normally impeded by the limited proliferative capacity of diploid somatic cells. In this sense, cellular senescence may serve as an anti-oncogenic defense, by limiting the "window of opportunity" for accrual of mutations jointly required for cancer. Both cellular escape from senescence, and subsequent selective progression of the tumor, would be rendered more likely and more rapid following the acquisition of a "hypermutator" In the latter four syndromes, genetic mutability is manifest in high rates of chromosomal aberration. Karyotypic alteration has also been implicated in many specific cancer types, such as gliomas (Kruse et Stewart and Bacchetti 1991 ), suggest that chromosomal instability may also be a characteristic of precancerous cells which ultimately give rise to chromosomally-unstable tumors.
TELOMERIC RECOMBINATION --ANOTHER MEANS TO JUSTIFY AN END
Telomeres, specialized nucleoprotein structures at the ends of chromosomes, contribute to genomic integrity by protecting genomic DNA from degradation and end-toend joining of chromosomes (Day etaL 1993) . The linear DNA duplex of each chromosome terminates at both ends in telomeric DNA--tandem arrays comprising hundreds to thousands of short oligonucleotide repeats (GGGTTA in the vertebrates), with a guanosine (G)-rich strand running 5' to 3' toward the terminus, extending beyond a cytosine (C)-rich complementary strand (Zakian 1989 Alternative mechanisms thus must exist for the maintenance, or episodic expansion, of telomere length in telomerase-negative cell lines. Although the process remains to be defined for mammalian cell lines, in yeast the regeneration of telomeric arrays can occur by a recombination mechanism apparently involving gene conversion (Wang and Zakian 1990 ). That a comparable pathway exists in mammals is suggested by detection of extrachromosomal telomeric DNA fragments in telomerase-negative immortal human cell lines, but not in telomerase-proficient lines or in normal human fibroblasts (Ogino et aL 1998) . Such fragments provide circumstantial evidence of intra-telomere recombination (e.g., excision between inverted telomeric repeats), whereas inter-telomere recombination would also have to occur in order to extend telomeres and hence replicative potential.
Immortalization of human fibroblasts, whether telomerase-dependent or independent, is associated with mutation or loss of p53 genes (Gollahon 1998 anti-oncogene inactivation. Lacking such selection, or facing adverse selection, hypermutable cells might never accumulate in sufficient numbers to support complete transformation. As telomerase-negative diploid cells approach the end of their replicative life spans, however, they could avoid the consequences of telomere shortening either by reactivating telomerase or by inter-telomere recombination (including gene conversion). In the latter case, cell selection would directly favor those cells with the highest recombination rates
INDUCTION OF RECOMBINATION BY SV40 LARGE TUMOR ANTIGEN
Simian virus 40 (SV40) is an oncogenic virus with a 5.3-kbp DNA genome. The virus encodes a multifunctional regulatory protein, the large tumor antigen (T antigen), which plays a variety of roles in controlling viral infection. Although expression of T antigen is necessary, it is not sufficient for tumorigenicity by SV40 (Tegtmeyer 1980 ), which appears to require subsequent mutational events following T antigen expression. T antigen induces DNA rearrangement and chromosomal aberration in expressing cells (Gurney and Gurney, 1989 ; Ray et aL 1990), suggesting genetic destabilization. The underlying mechanism appears to be homologous recombination, because chromosomal recombination events are markedly increased in human diploid fibroblasts following stable transformation (Cheng et aL 1997) or transient transfection (Shammas et aL 1997) with SV40 large T antigen. Nine clones of human diploid fibroblasts generated by stable transfection with SV40 large T antigen had recombination levels 2-to >5-fold higher than those in untransfected fibroblasts, dependent on continuous T antigen expression (Cheng et aL 1997) . Transient transfection of human diploid cells with SV40 T antigen elicited an average of 7-fold induction in chromosomal homologous recombination (Shammas et aL 1997) .
Elevation of homologous recombination is strongly correlated to induction of host DNA synthesis, by wildtype T antigen and a series of point mutants (Shammas etaL 1997) . In T antigen-transformed cells, regulation of both recombination and replication may be primarily mediated by a common molecule, p53. T antigen point mutants unable to bind p53 (Ray etaL 1996) lose most of their ability to elevate recombination (Shammas etaL 1997; and unpublished data). These and other studies (Mekeel et aL 1997) imply that loss of p53 function is associated with elevated levels of homologous recombination. Wild type p53 may regulate levels of recombination through its ability to bind and inactivate HsRAD51 recombinase (St0rzbecher 1996). In SV40 T antigentransformed cells, levels of homologous recombination and of HsRAD51 transcripts are approximately 4-fold higher than those in untransformed controls (Xia et aL 1997) . We proposed that T antigen binding to p53 protein can spare RAD51 recombinase activity, which otherwise would be sequestered by p53, resulting in simultaneous increases in DNA recombination and replication. This is consistent with our observation of a tight coupling between inductions of host DNA synthesis and homologous recombination (see next section).
Other mechanisms are clearly also involved. Protein interactions alone, as described above, cannot account for the increase we observed in RAD51 transcript levels within immortal cell lines, and in diploid fibroblasts upon T antigen introduction (Xia et aL 1997) . Because T antigen bound to distal regions of DNA can oligomerize in the presence of magnesium ions, to effect DNA looping (Schiedner et aL 1990) , the ability to physically associate distant regions of DNA may also contribute to its induction of recombination. Functional association between replication and recombination has also been observed for bacterial genomic DNA. Interconversion of DNA intermediates in the two processes (Morgan and Severini 1990) may provide a physical basis for this association. Moreover, Rec A is required in one of the early steps during an alternative mode of bacterial genomic DNA replication called "stable DNA replication" (Kogoma 1996) . A recent model for homologous recombination proposes that D-loops, formed by invasion of single-stranded DNA into a homologous double-stranded DNA duplex during recombination, serve as sites for primosome assembly (Asai etaL 1993) . The initiation of DNA replication would thus be coupled to the formation of recombination intermediates. Primosome assembly is initiated by the PriA protein, which is required for both recombination and replication in E. coli, and has been implicated in recruitment of DnaB helicase to the replication fork. Evidence that the function of PriA required for homologous recombination is primosome assembly rather than its ATPase or helicase activities (Kuchta and Willhelm 1991 ; Kogoma et al. 1996) , suggests the involvement of replication in recombination and vice versa.
In mammalian cells, T antigen helicase activity unwinds SV40 origin DNA and also interacts with DNA polymerase ~x:primase complex at the replication fork, thus participating in lagging-strand synthesis during DNA replication . Tanti The relationship between recombination and replication has been explored through comparing the induction of these processes by T-antigen, which can drive even senescent cells to enter S phase (Tsuji et aL 1983; Gorman and Cristofalo 1985) and induces DNA recombination by 2-to 7-fold (Cheng etaL 1997; Shammas et al. 1997) . The ability of wild-type and point mutants of T antigen to elevate recombination correlates strongly with their ability to induce host DNA synthesis (Shammas et al. 1997) . Moreover, inhibitors of DNA replication (aphidicolin and hydroxyurea) suppress SV40-induced homologous recombination and DNA synthesis to the same extent. As discussed above, the ability of T antigen to inactivate p53 is implicated in its ability to induce both recombination and replication. We also find that other oncogenes ( c-myc, c-H-ras, c-jun, c-fos, and erb-B2) induce recombination and host DNA synthesis concordantly (unpublished data), although none stimulates either process as strongly as T antigen.
In yeast and in human cells, RAD51 expression is regulated across the cell cycle, reaching a maximum at the G1/S boundary (Basile etaL 1992; Xia etal. 1997), just prior to genomic DNA replication. This would be consistent with co-induction of replication and recombination, which might reflect mutual regulation via p53, or other regulation of shared components catalyzing key steps in the two processes.
IMPLICATIONS FOR CANCER ETIOLOGY
Induction of DNA synthesis is a basic requirement for increased cellular proliferation and has been repeatedly implicated in the overall process of oncogenesis, and specifically in the action of tumor promoters (Busser and Lutz 1987; Yusof and Edwards 1990) . A rapidly cycling cell may carry more unrepaired DNA damage through to S phase, which may then activate recombinational repair pathways. However, it is also suggestive that the abilities of T antigen mutants to produce cell transformation (Ray et aL 1996) correlate well with their abilities to induce host DNA synthesis and recombination (Shammas et aL 1997) . These biological properties of T antigen may be linked through a common regulator, p53 (Xia et al. 1997) , which can bind and inactivate HsRAD51 recombinase (Sthrzbecher 1996) to limit the level of recombination. Loss of p53 function results in elevation of homologous recombination, whether it is inactivated by T antigen (Shammas etaL 1997; Xia etaL 1997) or by other mechanisms (Mekeel etaL 1997) . Products of the breast cancer-associated genes BRCA1 and BRCA2 also interact with the HsRAD51 recombinase (Scully et aL 1997; Feunteun 1998) , thereby regulating recombinational repair of DNA damage (Feunteun 1998). BRCA genes may play a role similar to p53 in this respect, since BRCA 1 and BRCA2 mutations can elevate the overall mutation rate, predisposing cells to cancer (Feunteun 1998) . Regulation of recombination-associated molecules can thus affect genomic integrity and the initiation of oncogenesis. The multiple mutations which must coincide within a cell lineage to achieve full transformation would normally have frequencies, individually, on the order of 10 .6 . If independent, three such events would coincide in 10 -18 cells, or in fewer than 0.1% of individuals, since over a lifetime our bodies comprise a total of roughly 10 is cells. The much higher prevalence of cancer actually observed could be reconciled by either an initiating elevation of mutation rates, or sequential episodes of mutation and clonal expansion (in which case the mutations are not independent). Increased mutation, and especially increased DNA rearrangement, are supported by the marked genetic instability of cancer cells (Lengauer etal. 1997 (Lengauer etal. , 1998 
